In type 2 diabetes, glargine and liraglutide each improved glycemic outcomes at 5 y vs. glimepiride or sitagliptin. Brown K, Donato AA. Ann Intern Med 2023 Jan 3. doi: 10.7326/J22-0104.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Brown K, Donato AA. In type 2 diabetes, glargine and liraglutide each improved glycemic outcomes at 5 y vs. glimepiride or sitagliptin. Ann Intern Med 2023 Jan 3. doi: 10.7326/J22-0104.
PMID: 36592465